Lupus & antiphospholipid syndrome

Beyond glomeruli in lupus nephritis: Impact of tubulointerstitial inflammation and interstitial fibrosis/tubular atrophy on renal function decline – A systematic review and meta-analysis

LupusPublished Systematic review and meta-analysis of retrospective studies

Authors' conclusion

This meta-analysis found that both interstitial fibrosis/tubular atrophy (IFTA) and tubulointerstitial inflammation (TII) are significantly associated with renal function decline in lupus nephritis, suggesting a worse prognosis.

Study context

Population
Adult patients with LN
Participants
3,607 patients21 retrospective studies
Comparison
Presence vs absence of tubulointerstitial inflammation (TII) or interstitial fibrosis/tubular atrophy (IFTA) on LN biopsy
Outcome
Renal function decline
Methodological detailsrandom-effects models, prespecified subgroup analyses by follow-up duration, leave-one-out sensitivity analyses, meta-regression
  • Random-effects models
  • Prespecified subgroup analyses by follow-up duration
  • Leave-one-out sensitivity analyses
  • Meta-regression

Pooled result

As reported in the abstract

Relative risk (95% CI)
TII
2.22(1.75–2.82)
IFTA
3.44(2.70–4.38)
TIIvs IFTA
0.78(0.59–1.03)

Further pooled results

Renal decline by follow-up duration (subgroup)

TII association stronger in studies with longer follow-up (>5 years); IFTA consistently elevated risk across follow-up strata

Publication bias

Egger's test: no evidence of publication bias
P = 0.9074

Meta-regression by glomerular pattern

TII association varied with distribution of proliferative glomerular classes; IFTA association not significantly modified

Original publication

Beyond glomeruli in lupus nephritis: Impact of tubulointerstitial inflammation and interstitial fibrosis/tubular atrophy on renal function decline – A systematic review and meta-analysis. Lupus. Published 20 March 2026. doi:10.1177/09612033261437467

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.